title: Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy.
authors.affiliation: Department of Medicine, University of California San Francisco School of Medicine, San Francisco, CA, USA.
authors.forename: S W
authors.initials: SW
authors.lastname: Wong
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, Tufts Medical Center, Boston, MA, USA.
authors.forename: D
authors.initials: D
authors.lastname: Larivee
authors.affiliation: Division of Hematology-Oncology, The John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Warner
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, Tufts Medical Center, Boston, MA, USA.|Division of Hematology-Oncology, The John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA.
authors.forename: K A
authors.initials: KA
authors.lastname: Sprague
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, Tufts Medical Center, Boston, MA, USA.|Division of Hematology-Oncology, The John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA.
authors.forename: T
authors.initials: T
authors.lastname: Fogaren
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, Tufts Medical Center, Boston, MA, USA.|Division of Hematology-Oncology, The John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA.
authors.forename: R L
authors.initials: RL
authors.lastname: Comenzo
mesh_terms: D000368:Aged; D064592:Autografts; D000069286:Bortezomib / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D000075363:Immunoglobulin Light-chain Amyloidosis / Q000097:blood / Q000628:therapy*; D060828:Induction Chemotherapy; D008297:Male; D008875:Middle Aged; D033581:Stem Cell Transplantation
chemical_list: D000069286:Bortezomib